These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6415861)

  • 1. Selective inhibition of thromboxane synthesis with dazoxiben in animals and man.
    Randall MJ
    Thromb Res Suppl; 1983; 4():81-5. PubMed ID: 6415861
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of platelet thromboxane synthesis by 7-(1-imidazolyl) heptanoic acid: dissociation from inhibition of aggregation.
    Grimm LJ; Knapp DR; Senator D; Halushka PV
    Thromb Res; 1981 Nov; 24(4):307-17. PubMed ID: 6801806
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis of thromboxane B2 in incubates of dog platelet-rich plasma with arachidonic acid and its inhibition by different drugs.
    Chignard M; Vargaftig BB; Sors H; Dray F
    Biochem Biophys Res Commun; 1978 Dec; 85(4):1631-9. PubMed ID: 743319
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro effects of acetaminophen and its analogues on human platelet aggregation and thromboxane B2 synthesis.
    Shorr RI; Kao KJ; Pizzo SV; Rauckman EJ; Rosen GM
    Thromb Res; 1985 Apr; 38(1):33-43. PubMed ID: 3923647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Y-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function.
    Mikashima H; Ochi H; Muramoto Y; Yasuda H; Tsuruta M; Maruyama Y
    Thromb Res; 1986 Aug; 43(4):455-68. PubMed ID: 3094191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L8027 and 1-nonyl-imidazole as non-selective inhibitors of thromboxane synthesis.
    Prancan AV; Lefort J; Chignard M; Gerozissis K; Dray F; Vargaftig BB
    Eur J Pharmacol; 1979 Dec; 60(4):287-97. PubMed ID: 527664
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazoles.
    Yoshimoto T; Yamamoto S; Hayaishi O
    Prostaglandins; 1978 Oct; 16(4):529-40. PubMed ID: 725083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.
    Parry MJ
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fenflumizole on aggregation ex vivo of human platelets and formation of thromboxane B2 and 6-keto-prostaglandin-F1 alpha.
    Vinge E; Corell T; Andersson KE
    Eur J Clin Pharmacol; 1984; 26(6):711-7. PubMed ID: 6436029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.
    Schumacher WA; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of thromboxane synthesis in guinea pig lung and human platelets by clotrimazole and other imidazole antifungals.
    Tolman EL; Fuller BL
    Biochem Pharmacol; 1983 Nov; 32(22):3488-90. PubMed ID: 6316985
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of platelet aggregation and adenosine 3':5'-monophosphate on the synthesis of thromboxane B2 in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    Adv Prostaglandin Thromboxane Res; 1980; 6():275-81. PubMed ID: 6247886
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of cetiedil on platelet aggregation and thromboxane synthesis.
    Yamaguchi A; Asakura T; Tanoue K; Yamazaki H
    Thromb Res; 1985 Feb; 37(3):391-400. PubMed ID: 2986312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD; Hamilton JG
    Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of thrombocyte aggregation and thromboxane B2 synthesis by diethylstilbestrol.
    Subbiah MT; Gallon L; Yunker R
    Pharmacology; 1980; 21(6):396-9. PubMed ID: 7220591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane A2 generation by the larval cestode, Taenia taeniaeformis.
    Leid RW; McConnell LA
    Clin Immunol Immunopathol; 1983 Jul; 28(1):67-76. PubMed ID: 6409486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin.
    Bertele V; De Gaetano G
    Eur J Pharmacol; 1982 Dec; 85(3-4):331-3. PubMed ID: 6295787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects.
    Patrono C; Ciabattoni G; Pinca E; Pugliese F; Castrucci G; De Salvo A; Satta MA; Peskar BA
    Thromb Res; 1980 Feb 1-15; 17(3-4):317-27. PubMed ID: 7368167
    [No Abstract]   [Full Text] [Related]  

  • 20. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
    Maguire MH; Csonka-Khalifah L
    Biochim Biophys Acta; 1987 Oct; 921(3):426-36. PubMed ID: 3117116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.